Shareholding disclosure
Addex Therapeutics Ltd
Collectively declared rate
3%
Threshold
Fell below threshold
Timeline
Published
30.05.2008
Transaction
22.05.2008
Transfer date
22.05.2008
Voting rights breakdown
Voting rights acquired0%
Voting rights sold0%
Below threshold3%
Declared beneficial owners · 6
A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.
Notice details
CategoryGroup of shareholders
ExchangeXSWX
Notification ID
T6265D6021
Beneficial owner
Sofinnova Capital IV FCPR
Declared address
Sofinnova Capital IV FCPR, Paris
The disclosure of shareholdings is triggered by the expiration of a lock-up agreement on May 22, 2008, that also comprised 28 other shareholders holding each less than 3% of the voting rights in Addex Pharmaceuticals Ltd. Contact person at Addex Pharmaceuticals Ltd.: Chris Maggos: +41 22 884 15 11.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open